Incyte Corporation
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

Last updated:

Abstract:

Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

4 May 2021

Issue date:

24 Mar 2022